1. Loktionov, A., Common gene polymorphisms, cancer progression and prognosis, Cancer Lett., 2004, vol. 208, pp. 1–33.
2. Romanyuk, O.P., Nikitchenko, N.V., Savina, N.V., et al., The polymorphism of DNA repair genes XPD, XRCC1, OGG1,and ERCC6, life expectancy, and the inclination to smoke, Russ. J. Genet., 2014, vol. 50, no. 8, pp. 860–869.
3. Ying, L. and Hofseth, L.J., An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer, Cancer Res., 2007, vol. 67, no. 4, pp. 1407–1410.
4. Safarinejad, M.R., Safarinejad, S., and Shafiei, N., Effects of the T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer, Urol. Oncol., 2013, vol. 31, no. 7, pp. 1132–1140.
5. Mustafina, O.E., Shagisultanova, E.I., Nasybullin, T.R., et al., Endothelial nitric oxide synthase gene minisatellite polymorphism in populations of the Volga–Ural Region and analysis of its association with myocardial Infarction and essential hypertension, Russ. J. Genet., 2001, vol. 37, no. 5, pp. 546–552.